ResMed Inc. (RMD) News
Filter RMD News Items
RMD News Results
Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
RMD News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest RMD News From Around the Web
Below are the latest news stories about RESMED INC that investors may wish to consider to help them evaluate RMD as an investment opportunity.
Is There An Opportunity With ResMed Inc.'s (NYSE:RMD) 31% Undervaluation?Key Insights Using the 2 Stage Free Cash Flow to Equity, ResMed fair value estimate is US$338 ResMed is estimated to be... |
GMED Stock Rides on NuVasive Synergy Benefits Amid Macro IssuesGlobus Medical is seeing notable gains across its product portfolio in expandables, biologics, MIS screws, 3D printed implants and cervical offerings. |
How to Boost Your Portfolio with Top Medical Stocks Set to Beat EarningsWhy investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates. |
Here's Why You Should Retain HealthEquity Stock in Your Portfolio NowHQY's sustained strength in HSAs raises optimism about the stock. |
Reasons to Retain The Cooper Companies Stock in Your Portfolio NowCOO benefits from strength in its business segments. Its acquisitions are likely to drive the top line. However, a rise in selling, general and administrative expenses is concerning. |
MYGN Stock Gains Following Collaboration With Hannah StormMyriad Genetics enters into an agreement with Hannah Storm, who will be the Myriad Genetics Breast Cancer Risk Assessment Program ambassador. |
ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025SAN DIEGO, Jan. 09, 2025 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2025 on Thursday, January 30, 2025, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: • Location:https://investor.resmed.com• |
3 S&P 500 Earnings Growth Stocks to Buy in 2025: CMG, RMD, NOWChipotle Mexican Grill, Ulta Beauty and ServiceNow are currently exhibiting superb earnings growth. |
Expanding Global Network, Vaccine Sales Support PAHC StockPhibro Animal Health is focusing on new developments along with incremental registrations and growing volumes of existing vaccine technologies. |
BSX Stock Rises Following Bolt Medical Acquisition Deal AnnouncementBoston Scientific inks a new agreement to acquire Bolt Medical, developer of Bolt IVL, for approximately $443 million. |